SCHEMBL22400166

SCHEMBL22400166

CC(C)C(C)[C@H]1COCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005721 0.82
SCHEMBL516848 0.82
SCHEMBL516849 0.82
Hydrochloric Acid SCHEMBL1317097 0.80
Bromide SCHEMBL1831534 0.80
Bromide SCHEMBL1831532 0.80
Hydrochloric Acid SCHEMBL19285480 0.80
Hydrochloric Acid SCHEMBL6133053 0.80
SCHEMBL15496994 0.79
SCHEMBL7426486 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766877-B2 Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-09-08 US disclosed